Torrent Pharma posts 287cr net profit in Q4

Ahmedabad: Homegrown pharma major, Torrent Pharmaceuticals Ltd posted Rs 287 crore in profit for the fourth quarter of the fiscal year 2022-23, the company said on Tuesday in its stock exchange filing. Torrent Pharma posted a net loss of Rs 118 crore during the corresponding period. During the full fiscal year 2022-23, its net profit reached Rs 1,245 crore, up 60% against Rs 777 crore in the previous fiscal.
The board of the pharma company also recommended a dividend of Rs 8 per share, subject to the shareholders’ approval.The company’s revenue rose to Rs 2,491 crore for the fourth quarter compared to Rs 2,131 crore in the year-ago period, Torrent Pharma said in a statement.
The flagship company of the Torrent Group, Torrent Pharma, is among the top 5 in the therapeutics segments of cardiovascular (CV), gastro intestinal (GI), central nervous system (CNS), vitamins minerals nutritionals (VMN), and cosmo-dermatology and is ranked 6th in the Indian pharmaceuticals industry.
The company’s share price closed at Rs 1,717.15 on the BSE.